Zheng Y - Search Results

1

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.

Luo J, Xie Y, Zheng Y, Wang C, Qi F, Hu J, Xu Y. Luo J, et al. Among authors: zheng y. Cancer Med. 2020 Jun;9(12):4310-4323. doi: 10.1002/cam4.2983. Epub 2020 Apr 20. Cancer Med. 2020. PMID: 32311223 Free PMC article.

2

Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β A.

Zheng Y, Gao Y, Li X, Si S, Xu H, Qi F, Wang J, Cheng G, Hua L, Yang H. Zheng Y, et al. Onco Targets Ther. 2018 Aug 17;11:4965-4977. doi: 10.2147/OTT.S163680. eCollection 2018. Onco Targets Ther. 2018. PMID: 30154665 Free PMC article.

3

Efficacy characteristics of different therapeutic modalities for locally advanced prostate cancer: a Bayesian network meta-analysis of randomized controlled trials.

Xue J, Wang Y, Zheng Y, Zhang J, Qi F, Cheng H, Si S, Li R, Li X, Qin Z, Yu B, Zou Q. Xue J, et al. Among authors: zheng y. Ann Transl Med. 2018 Sep;6(18):358. doi: 10.21037/atm.2018.08.38. Ann Transl Med. 2018. PMID: 30370285 Free PMC article.

4

Surgical intervention in renal cell carcinoma patients with lung and bronchus metastasis is associated with longer survival time: a population-based analysis.

Lin S, Zheng Y, Qin Z, Hu X, Qi F, Yin R, Xu L, Li X. Lin S, et al. Among authors: zheng y. Ann Transl Med. 2019 Jul;7(14):323. doi: 10.21037/atm.2019.06.02. Ann Transl Med. 2019. PMID: 31475193 Free PMC article.

5

A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.

Xu Z, Li X, Qi F, Hu X, Zheng Y, Cai H, Xu T, Yu B, Zou Q. Xu Z, et al. Among authors: zheng y. Transl Androl Urol. 2019 Aug;8(4):339-345. doi: 10.21037/tau.2019.06.25. Transl Androl Urol. 2019. PMID: 31555557 Free PMC article.

6

Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.

Zhang C, Zheng Y, Li X, Hu X, Qi F, Luo J. Zhang C, et al. Among authors: zheng y. Ann Transl Med. 2019 Sep;7(18):427. doi: 10.21037/atm.2019.08.113. Ann Transl Med. 2019. PMID: 31700863 Free PMC article.

7

Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.

Zhang C, Shen K, Zheng Y, Qi F, Luo J. Zhang C, et al. Among authors: zheng y. Cancer Med. 2020 Jan;9(2):768-782. doi: 10.1002/cam4.2665. Epub 2019 Dec 3. Cancer Med. 2020. PMID: 31794632 Free PMC article.

8

Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.

Qi F, Xu Y, Zheng Y, Li X, Gao Y. Qi F, et al. Among authors: zheng y. Ann Transl Med. 2019 Oct;7(20):531. doi: 10.21037/atm.2019.09.160. Ann Transl Med. 2019. PMID: 31807513 Free PMC article.

9

Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.

Li X, Gao Y, Xu Z, Zhang Z, Zheng Y, Qi F. Li X, et al. Among authors: zheng y. Cancer Med. 2020 Feb;9(3):1161-1172. doi: 10.1002/cam4.2774. Epub 2019 Dec 19. Cancer Med. 2020. PMID: 31856409 Free PMC article.

10

Clinical characteristics and genetic testing of an atypical familial von Hippel-Lindauzon renal cell carcinoma.

Wang J, Qi F, Zhang P, Xu Z, Zheng Y, Cai H, Yu B, Xu T, Li X, Zou Q. Wang J, et al. Among authors: zheng y. Ann Transl Med. 2019 Nov;7(22):677. doi: 10.21037/atm.2019.10.09. Ann Transl Med. 2019. PMID: 31930078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,387 results

Search Page

Filters